Nuclear Medicine System Market Report

Global Nuclear Medicine System Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Mar 12, 2022
  • PAGES：139
  • REPORT CODE：GMM815609
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Nuclear medicine is a medical specialty that uses radioactive tracers (radiopharmaceuticals) to assess bodily functions and to diagnose and treat disease. Specially designed cameras allow doctors to track the path of these radioactive tracers. Single Photon Emission Computed Tomography or SPECT and Digirad Emission Tomography or PET scans are the two most common imaging modalities in nuclear medicine.

    Nuclear Medicine System market report explains the definition, types, applications, major countries, and major players of the Nuclear Medicine System market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • GE Healthcare

    • Neusoft Medical Systems

    • Koninklijke Philips

    • SurgicEye

    • Mediso Medical Imaging Systems

    • Positron

    • Siemens Healthineers

    • Digirad

    By Type:

    • Single-Photon Emission Computed Tomography (SPECT) Systems

    • Hybrid Digirad Emission Tomography (PET) Systems

    • Planar Scintigraphy

    By End-User:

    • Hospitals

    • Imaging Centers

    • Research Institutes

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Nuclear Medicine System Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Nuclear Medicine System Outlook to 2028- Original Forecasts

    • 2.2 Nuclear Medicine System Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Nuclear Medicine System Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Nuclear Medicine System Market- Recent Developments

    • 6.1 Nuclear Medicine System Market News and Developments

    • 6.2 Nuclear Medicine System Market Deals Landscape

    7 Nuclear Medicine System Raw Materials and Cost Structure Analysis

    • 7.1 Nuclear Medicine System Key Raw Materials

    • 7.2 Nuclear Medicine System Price Trend of Key Raw Materials

    • 7.3 Nuclear Medicine System Key Suppliers of Raw Materials

    • 7.4 Nuclear Medicine System Market Concentration Rate of Raw Materials

    • 7.5 Nuclear Medicine System Cost Structure Analysis

      • 7.5.1 Nuclear Medicine System Raw Materials Analysis

      • 7.5.2 Nuclear Medicine System Labor Cost Analysis

      • 7.5.3 Nuclear Medicine System Manufacturing Expenses Analysis

    8 Global Nuclear Medicine System Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Nuclear Medicine System Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Nuclear Medicine System Export by Region (Top 10 Countries) (2017-2028)

    9 Global Nuclear Medicine System Market Outlook by Types and Applications to 2022

    • 9.1 Global Nuclear Medicine System Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Single-Photon Emission Computed Tomography (SPECT) Systems Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Hybrid Digirad Emission Tomography (PET) Systems Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Planar Scintigraphy Consumption and Growth Rate (2017-2022)

    • 9.2 Global Nuclear Medicine System Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Imaging Centers Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Research Institutes Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Nuclear Medicine System Market Analysis and Outlook till 2022

    • 10.1 Global Nuclear Medicine System Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Nuclear Medicine System Consumption (2017-2022)

      • 10.2.2 Canada Nuclear Medicine System Consumption (2017-2022)

      • 10.2.3 Mexico Nuclear Medicine System Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Nuclear Medicine System Consumption (2017-2022)

      • 10.3.2 UK Nuclear Medicine System Consumption (2017-2022)

      • 10.3.3 Spain Nuclear Medicine System Consumption (2017-2022)

      • 10.3.4 Belgium Nuclear Medicine System Consumption (2017-2022)

      • 10.3.5 France Nuclear Medicine System Consumption (2017-2022)

      • 10.3.6 Italy Nuclear Medicine System Consumption (2017-2022)

      • 10.3.7 Denmark Nuclear Medicine System Consumption (2017-2022)

      • 10.3.8 Finland Nuclear Medicine System Consumption (2017-2022)

      • 10.3.9 Norway Nuclear Medicine System Consumption (2017-2022)

      • 10.3.10 Sweden Nuclear Medicine System Consumption (2017-2022)

      • 10.3.11 Poland Nuclear Medicine System Consumption (2017-2022)

      • 10.3.12 Russia Nuclear Medicine System Consumption (2017-2022)

      • 10.3.13 Turkey Nuclear Medicine System Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Nuclear Medicine System Consumption (2017-2022)

      • 10.4.2 Japan Nuclear Medicine System Consumption (2017-2022)

      • 10.4.3 India Nuclear Medicine System Consumption (2017-2022)

      • 10.4.4 South Korea Nuclear Medicine System Consumption (2017-2022)

      • 10.4.5 Pakistan Nuclear Medicine System Consumption (2017-2022)

      • 10.4.6 Bangladesh Nuclear Medicine System Consumption (2017-2022)

      • 10.4.7 Indonesia Nuclear Medicine System Consumption (2017-2022)

      • 10.4.8 Thailand Nuclear Medicine System Consumption (2017-2022)

      • 10.4.9 Singapore Nuclear Medicine System Consumption (2017-2022)

      • 10.4.10 Malaysia Nuclear Medicine System Consumption (2017-2022)

      • 10.4.11 Philippines Nuclear Medicine System Consumption (2017-2022)

      • 10.4.12 Vietnam Nuclear Medicine System Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Nuclear Medicine System Consumption (2017-2022)

      • 10.5.2 Colombia Nuclear Medicine System Consumption (2017-2022)

      • 10.5.3 Chile Nuclear Medicine System Consumption (2017-2022)

      • 10.5.4 Argentina Nuclear Medicine System Consumption (2017-2022)

      • 10.5.5 Venezuela Nuclear Medicine System Consumption (2017-2022)

      • 10.5.6 Peru Nuclear Medicine System Consumption (2017-2022)

      • 10.5.7 Puerto Rico Nuclear Medicine System Consumption (2017-2022)

      • 10.5.8 Ecuador Nuclear Medicine System Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Nuclear Medicine System Consumption (2017-2022)

      • 10.6.2 Kuwait Nuclear Medicine System Consumption (2017-2022)

      • 10.6.3 Oman Nuclear Medicine System Consumption (2017-2022)

      • 10.6.4 Qatar Nuclear Medicine System Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Nuclear Medicine System Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Nuclear Medicine System Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Nuclear Medicine System Consumption (2017-2022)

      • 10.7.2 South Africa Nuclear Medicine System Consumption (2017-2022)

      • 10.7.3 Egypt Nuclear Medicine System Consumption (2017-2022)

      • 10.7.4 Algeria Nuclear Medicine System Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Nuclear Medicine System Consumption (2017-2022)

      • 10.8.2 New Zealand Nuclear Medicine System Consumption (2017-2022)

    11 Global Nuclear Medicine System Competitive Analysis

    • 11.1 GE Healthcare

      • 11.1.1 GE Healthcare Company Details

      • 11.1.2 GE Healthcare Nuclear Medicine System Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 GE Healthcare Nuclear Medicine System Main Business and Markets Served

      • 11.1.4 GE Healthcare Nuclear Medicine System Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Neusoft Medical Systems

      • 11.2.1 Neusoft Medical Systems Company Details

      • 11.2.2 Neusoft Medical Systems Nuclear Medicine System Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Neusoft Medical Systems Nuclear Medicine System Main Business and Markets Served

      • 11.2.4 Neusoft Medical Systems Nuclear Medicine System Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Koninklijke Philips

      • 11.3.1 Koninklijke Philips Company Details

      • 11.3.2 Koninklijke Philips Nuclear Medicine System Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Koninklijke Philips Nuclear Medicine System Main Business and Markets Served

      • 11.3.4 Koninklijke Philips Nuclear Medicine System Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 SurgicEye

      • 11.4.1 SurgicEye Company Details

      • 11.4.2 SurgicEye Nuclear Medicine System Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 SurgicEye Nuclear Medicine System Main Business and Markets Served

      • 11.4.4 SurgicEye Nuclear Medicine System Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Mediso Medical Imaging Systems

      • 11.5.1 Mediso Medical Imaging Systems Company Details

      • 11.5.2 Mediso Medical Imaging Systems Nuclear Medicine System Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Mediso Medical Imaging Systems Nuclear Medicine System Main Business and Markets Served

      • 11.5.4 Mediso Medical Imaging Systems Nuclear Medicine System Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Positron

      • 11.6.1 Positron Company Details

      • 11.6.2 Positron Nuclear Medicine System Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Positron Nuclear Medicine System Main Business and Markets Served

      • 11.6.4 Positron Nuclear Medicine System Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Siemens Healthineers

      • 11.7.1 Siemens Healthineers Company Details

      • 11.7.2 Siemens Healthineers Nuclear Medicine System Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Siemens Healthineers Nuclear Medicine System Main Business and Markets Served

      • 11.7.4 Siemens Healthineers Nuclear Medicine System Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Digirad

      • 11.8.1 Digirad Company Details

      • 11.8.2 Digirad Nuclear Medicine System Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Digirad Nuclear Medicine System Main Business and Markets Served

      • 11.8.4 Digirad Nuclear Medicine System Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    12 Global Nuclear Medicine System Market Outlook by Types and Applications to 2028

    • 12.1 Global Nuclear Medicine System Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Single-Photon Emission Computed Tomography (SPECT) Systems Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Hybrid Digirad Emission Tomography (PET) Systems Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Planar Scintigraphy Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Nuclear Medicine System Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Imaging Centers Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Nuclear Medicine System Market Analysis and Outlook to 2028

    • 13.1 Global Nuclear Medicine System Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.2.2 Canada Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Nuclear Medicine System Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.3.2 UK Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.3.3 Spain Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.3.5 France Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.3.6 Italy Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.3.8 Finland Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.3.9 Norway Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.3.11 Poland Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.3.12 Russia Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Nuclear Medicine System Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.4.2 Japan Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.4.3 India Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Nuclear Medicine System Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.5.3 Chile Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.5.6 Peru Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Nuclear Medicine System Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.6.3 Oman Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Nuclear Medicine System Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Nuclear Medicine System Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Nuclear Medicine System Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Nuclear Medicine System Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Nuclear Medicine System

    • Figure of Nuclear Medicine System Picture

    • Table Global Nuclear Medicine System Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Nuclear Medicine System Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Single-Photon Emission Computed Tomography (SPECT) Systems Consumption and Growth Rate (2017-2022)

    • Figure Global Hybrid Digirad Emission Tomography (PET) Systems Consumption and Growth Rate (2017-2022)

    • Figure Global Planar Scintigraphy Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Imaging Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Research Institutes Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Nuclear Medicine System Consumption by Country (2017-2022)

    • Table North America Nuclear Medicine System Consumption by Country (2017-2022)

    • Figure United States Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Canada Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Mexico Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Table Europe Nuclear Medicine System Consumption by Country (2017-2022)

    • Figure Germany Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure UK Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Spain Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Belgium Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure France Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Italy Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Denmark Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Finland Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Norway Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Sweden Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Poland Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Russia Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Turkey Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Table APAC Nuclear Medicine System Consumption by Country (2017-2022)

    • Figure China Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Japan Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure India Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure South Korea Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Thailand Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Singapore Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Philippines Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Table South America Nuclear Medicine System Consumption by Country (2017-2022)

    • Figure Brazil Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Colombia Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Chile Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Argentina Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Peru Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Table GCC Nuclear Medicine System Consumption by Country (2017-2022)

    • Figure Bahrain Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Oman Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Qatar Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Table Africa Nuclear Medicine System Consumption by Country (2017-2022)

    • Figure Nigeria Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure South Africa Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Egypt Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure Algeria Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Table Oceania Nuclear Medicine System Consumption by Country (2017-2022)

    • Figure Australia Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Nuclear Medicine System Consumption and Growth Rate (2017-2022)

    • Table GE Healthcare Company Details

    • Table GE Healthcare Nuclear Medicine System Sales, Price, Value and Gross Profit (2017-2022)

    • Table GE Healthcare Nuclear Medicine System Main Business and Markets Served

    • Table GE Healthcare Nuclear Medicine System Product Portfolio

    • Table Neusoft Medical Systems Company Details

    • Table Neusoft Medical Systems Nuclear Medicine System Sales, Price, Value and Gross Profit (2017-2022)

    • Table Neusoft Medical Systems Nuclear Medicine System Main Business and Markets Served

    • Table Neusoft Medical Systems Nuclear Medicine System Product Portfolio

    • Table Koninklijke Philips Company Details

    • Table Koninklijke Philips Nuclear Medicine System Sales, Price, Value and Gross Profit (2017-2022)

    • Table Koninklijke Philips Nuclear Medicine System Main Business and Markets Served

    • Table Koninklijke Philips Nuclear Medicine System Product Portfolio

    • Table SurgicEye Company Details

    • Table SurgicEye Nuclear Medicine System Sales, Price, Value and Gross Profit (2017-2022)

    • Table SurgicEye Nuclear Medicine System Main Business and Markets Served

    • Table SurgicEye Nuclear Medicine System Product Portfolio

    • Table Mediso Medical Imaging Systems Company Details

    • Table Mediso Medical Imaging Systems Nuclear Medicine System Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mediso Medical Imaging Systems Nuclear Medicine System Main Business and Markets Served

    • Table Mediso Medical Imaging Systems Nuclear Medicine System Product Portfolio

    • Table Positron Company Details

    • Table Positron Nuclear Medicine System Sales, Price, Value and Gross Profit (2017-2022)

    • Table Positron Nuclear Medicine System Main Business and Markets Served

    • Table Positron Nuclear Medicine System Product Portfolio

    • Table Siemens Healthineers Company Details

    • Table Siemens Healthineers Nuclear Medicine System Sales, Price, Value and Gross Profit (2017-2022)

    • Table Siemens Healthineers Nuclear Medicine System Main Business and Markets Served

    • Table Siemens Healthineers Nuclear Medicine System Product Portfolio

    • Table Digirad Company Details

    • Table Digirad Nuclear Medicine System Sales, Price, Value and Gross Profit (2017-2022)

    • Table Digirad Nuclear Medicine System Main Business and Markets Served

    • Table Digirad Nuclear Medicine System Product Portfolio

    • Figure Global Single-Photon Emission Computed Tomography (SPECT) Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hybrid Digirad Emission Tomography (PET) Systems Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Planar Scintigraphy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Imaging Centers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Nuclear Medicine System Consumption Forecast by Country (2022-2028)

    • Table North America Nuclear Medicine System Consumption Forecast by Country (2022-2028)

    • Figure United States Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Nuclear Medicine System Consumption Forecast by Country (2022-2028)

    • Figure Germany Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Nuclear Medicine System Consumption Forecast by Country (2022-2028)

    • Figure China Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Nuclear Medicine System Consumption Forecast by Country (2022-2028)

    • Figure Brazil Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Nuclear Medicine System Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Nuclear Medicine System Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Nuclear Medicine System Consumption Forecast by Country (2022-2028)

    • Figure Australia Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Nuclear Medicine System Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US